Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study
| Primer Autor |
Rosengren, Annika
|
| Co-autores |
Smyth, Andrew
Rangarajan, Sumathy
Ramasundarahettige, Chinthanie
Bangdiwala, Shrikant, I
AlHabib, Khalid F.
Avezum, Alvaro
Bostrom, Kristina Bengtsson
Chifamba, Jephat
Gulec, Sadi
Gupta, Rajeev
Igumbor, Ehi U.
Iqbal, Romaina
Ismail, Norhassim
Joseph, Philip
Kaur, Manmeet
Khatib, Rasha
Kruger, Iolanthe M.
Lamelas, Pablo
Lanas, Fernando
Lear, Scott A.
Li, Wei
Wang, Chuangshi
Quiang, Deren
Wang, Yang
Lopez-Jaramillo, Patricio
Mohammadifard, Noushin
Mohan, Viswanathan
Mony, Prem K.
Poirier, Paul
Srilatha, Sarojiniamfna
Szuba, Andrzej
Teo, Koon
Wielgosz, Andreas
Yeates, Karen E.
Yusoff, Khalid
Yusuf, Rita
Yusufali, Afzalhusein H.
Attaei, Marjan W.
McKee, Martin
Yusuf, Salim
|
| Título |
Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study
|
| Editorial |
ELSEVIER SCI LTD
|
| Revista |
LANCET GLOBAL HEALTH
|
| Lenguaje |
English
|
| Tipo de Recurso |
artículo original
|
| Derecho de Acceso |
acceso abierto
|
| Description |
SY is supported by the Mary W Burke endowed chair of the Heart and Stroke Foundation of Ontario. The PURE study is an investigator-initiated study that is funded by the Population Health Research Institute, the Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario, Support from the Canadian Institutes of Health Research Strategy for Patient Oriented Research, through the Ontario SPOR Support Unit, as well as the Ontario Ministry of Health and Long-Term Care, and through unrestricted grants from several pharmaceutical companies (with major contributions from AstraZeneca [Canada], Sanofi-Aventis [France and Canada], Boehringer Ingelheim [Germany and Canada], Servier, and GlaxoSmithKline), and additional contributions from Novartis and King Pharma and various national or local organisations in participating countries. These various national or local organisations include: Argentina: Fundacion ECLA (Estudios Clinicos Latino America); Bangladesh: Independent University, Bangladesh and Mitra and Associates; Brazil: Unilever Health Institute, Brazil; Canada: Public Health Agency of Canada and Champlain Cardiovascular Disease Prevention Network; Chile: Universidad de la Frontera; China: National Center for Cardiovascular Diseases and ThinkTank Research Center for Health Development; Colombia: Colciencias (grant nos 6566-04-18062 and 6517-777-58228); India: Indian Council of Medical Research; Malaysia: Ministry of Science, Technology and Innovation of Malaysia (grant no 100-IRDC/BIOTEK 16/6/21 [13/2007 and 07-05-IFN-BPH 010), Ministry of Higher Education of Malaysia (grant no 600-RMI/LRGS/5/3 [2/2011]), Universiti Teknologi MARA, Universiti Kebangsaan Malaysia (UKM-Hejim-Komuniti-15-2010); occupied Palestinian territory: the United Nations Relief and Works Agency for Palestine Refugees in the Near East, occupied Palestinian territory; International Development Research Centre, Canada; Philippines: Philippine Council for Health Research and Development; Poland: Polish Ministry of Science and Higher Education (grant no 290/W-PURE/2008/0), Wroclaw Medical University; Saudi Arabia: Saudi Heart Association, Dr Mohammad Alfagih Hospital, The Deanship of Scientific Research at King Saud University, Riyadh, Saudi Arabia (research group no RG-1436-013); South Africa: The North-West University, SA and Netherlands Programme for Alternative Development, National Research Foundation, Medical Research Council of South Africa, The South Africa Sugar Association, Faculty of Community and Health Sciences; Sweden: grants from the Swedish state under the agreement concerning research and education of doctors; the Swedish Heart and Lung Foundation; the Swedish Research Council; the Swedish Council for Health, Working Life and Welfare, King Gustaf V's and Queen Victoria Freemason's Foundation, AFA Insurance; Turkey: Metabolic Syndrome Society, AstraZeneca, Sanofi-Aventis; United Arab Emirates: Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences and Dubai Health Authority, Dubai.
|
| doi |
10.1016/S2214-109X(19)30045-2
|
| Formato Recurso |
pdf
|
| Ubicación del archivo | |
| Disciplinas de la OCDE |
Salud Pública y Ambiental
Sociología
Política de Salud y Servicios
Sistema Cardiovascular y Cardiaco
|
| Id de Web of Science |
WOS:000467822500020
|
| Access Rights |
acceso abierto
|
| Derechos de acceso |
acceso abierto
|
| Formato |
pdf
|
| Título de la cita (Recomendado-único) |
Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study
|
| Identificador del recurso (Mandatado-único) |
artículo original
|
| Versión del recurso (Recomendado-único) |
version publicada
|
| ISSN |
2214-109X
|
| Tipo de ruta |
dorada
verde
|
- Colecciones
- Colección Publicaciones Científicas
cienciaabierta.ufro.cl
ciencia.abierta@ufrontera.cl